Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Hansen

Showing results (111-120 of 408) with videos related to

Pageof 41
Sort By:
European Journal of Cancer & Clinical Oncology|March 1, 1988
High-dose ketoconazole to untreated stage D prostate cancerK Aabo, M Kjaer, H H Hansen
Cancer Chemotherapy and Pharmacology|January 1, 1983
Phase-I study of alpha-1,3,5-triglycidyl-s-triazinetrione (NSC 296934)P Dombernowsky, B Lund, H H Hansen
Journal of Internal Medicine|July 4, 1998
Smoking cessation in patients with stable or unstable ischaemic heart diseaseH H Hansen, B Vammen, M K Jensen
Cancer Treatment Reviews|January 1, 1993
Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine)B Lund, P E Kristjansen, H H Hansen
Cancer Treatment Reports|May 1, 1978
Unpredictable hematologic toxicity of weekly ddmpM Hansen, M E Lau, H H Hansen
Cancer Treatment Reviews|June 1, 1984
Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lungJ A Elliott, K Osterlind, H H Hansen
Cancer|December 1, 1983
The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patientsF R Hirsch, K Osterlind, H H Hansen
Scandinavian Journal of Respiratory Diseases|December 1, 1977
Mepacrine hydrochloride in the treatment of malignant pleural effusion. A controlled randomized trialJ Mejer, K M Mortensen, H H Hansen
Seminars in Oncology|September 1, 1978
Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinomaH H Hansen, P Dombernowsky, F R Hirsch
Cancer Treatment Reviews|December 1, 1990
Second-line chemotherapy in small cell lung cancerM Andersen, P E Kristjansen, H H Hansen
Pageof 41

Showing results (111-120 of 408) with videos related to

Sort By:
Pageof 41
European Journal of Cancer & Clinical Oncology|March 1, 1988
High-dose ketoconazole to untreated stage D prostate cancerK Aabo, M Kjaer, H H Hansen
Cancer Chemotherapy and Pharmacology|January 1, 1983
Phase-I study of alpha-1,3,5-triglycidyl-s-triazinetrione (NSC 296934)P Dombernowsky, B Lund, H H Hansen
Journal of Internal Medicine|July 4, 1998
Smoking cessation in patients with stable or unstable ischaemic heart diseaseH H Hansen, B Vammen, M K Jensen
Cancer Treatment Reviews|January 1, 1993
Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine)B Lund, P E Kristjansen, H H Hansen
Cancer Treatment Reports|May 1, 1978
Unpredictable hematologic toxicity of weekly ddmpM Hansen, M E Lau, H H Hansen
Cancer Treatment Reviews|June 1, 1984
Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lungJ A Elliott, K Osterlind, H H Hansen
Cancer|December 1, 1983
The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patientsF R Hirsch, K Osterlind, H H Hansen
Scandinavian Journal of Respiratory Diseases|December 1, 1977
Mepacrine hydrochloride in the treatment of malignant pleural effusion. A controlled randomized trialJ Mejer, K M Mortensen, H H Hansen
Seminars in Oncology|September 1, 1978
Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinomaH H Hansen, P Dombernowsky, F R Hirsch
Cancer Treatment Reviews|December 1, 1990
Second-line chemotherapy in small cell lung cancerM Andersen, P E Kristjansen, H H Hansen
Pageof 41